Sign inJoin waitlistJoin the waitlist

CC

Charles Conway

Director, Treatment Resistant Depression and Neurostimulation Clinic · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Psychiatry
Duke University Hospital
1995–1999
University of Missouri School of Medicine
1991–1995
University of Missouri Columbia, 1995
1987–1991

Research

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study
Biological Psychiatry · 2005 · 280 citations
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and…
American Journal of Psychiatry · 2017 · 260 citations
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
Journal of Psychiatric Research · 2019 · 225 citations

SA
Scott Aaronson
25 papers
CZ
Charles Zorumski
14 papers
PN
Peter Nagele
14 papers
Yvette Sheline
13 papers
Michael Thase
12 papers
Mark George
11 papers
Matthew Macaluso
11 papers
Anthony Rothschild
10 papers
Boadie Dunlop
9 papers
BF
Brent Forester
9 papers
Charles DeBattista
9 papers
JG
John Greden
9 papers

Grants

Nmda Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
National Institute of Mental Health · R21
Contact PI · $419.4K · Washington University
2016–2020
Fmri Studies of Emotional Circuitry in Depression
National Institute of Mental Health · R01
Contact PI · $401.7K · Washington University
2003–2014
Vagus Nerve Stimulation for Depression: PET Studies
National Institute of Mental Health · K08
Contact PI · $838.6K · Washington University
2007–2013

Clinical trials

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
Principal investigator · Terminated
LivaNova
2021–2024
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Principal investigator · Recruiting
LivaNova
2019–2030
Nitrous Oxide- Suicidal Ideation
Principal investigator · Enrolling by invitation · Phase 1
Washington University School of Medicine
2018–2026
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
Principal investigator · Terminated · Phase 4
Washington University School of Medicine
2018–2019